With Motor Neurone Disease affecting more than 5,000 adults in the UK and survival rates on average of 18 months, there is an urgent need to find new treatment options.
In this article, we sat down with Dr Brian Dickie, director of research development at the MND Association, which has just announced a £5 million funding injection to enable more patients take part in vital clinical trials.
He shares his insights on the current state of research into MND and how the funding hopes to advance this.
Unlock this article to read the full interview and learn more about:
- Promising lines of investigation and potential treatment pathways for MND
- How gene therapy is leading to some "never seen before" results
- The role AI can play in helping to manage the condition
- Legal4 weeks ago
APIL warns increasing court fees may price out injured claimants
- Brain injury news2 weeks ago
Patients and professionals discuss benefits of canoeing and kayaking on brain injury rehab
- Stroke news3 weeks ago
‘It got me focused on moving forward’ Alex’s recovery from a stroke
- Brain injury news1 week ago
Introducing Owl Barn – a pioneering new rehab centre in Cumbria
- Brain injury news3 weeks ago
St Andrew’s Healthcare: Extending highly specialist neurobehavioural care
- News4 days ago
Daily Round Up: Wednesday 21 February
- Brain injury news4 weeks ago
Children with mTBIs at increased risk of affective and behavioural disorders – study
- News2 weeks ago
Your NR Headlines: Friday 9 February